Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients
Clinical trial NCT04793399 · TERMINATED
Trial details
- NCT number
- NCT04793399
- Sponsor
- Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-24
- Primary completion
- 2021-09-24
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.